Delivery Order SPE2DB22D2206-SPE2DB25FJX01
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,041.38 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract utilized competitive procurement procedures with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,108.54 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mL on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency (DLA) awarded a $5,066.24 delivery order contract to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, was competitively awarded without a set-aside designation. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,411.86 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable pharmaceutical product used for treating inflammatory conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Humira (cf) Pen 40 mg/0.4 mls, a pharmaceutical product used primarily for the treatment of inflammatory conditions. This firm fixed price delivery order, valued at $1,510.60, represents a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp received a $12,823.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products, with completion targeted for September 4, 2025. This non-set-aside contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitive award to the established pharmaceutical distributor, which maintains significant federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical product with a ceiling value of $2,272.77. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and performance to be executed from the vendor's location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in treating autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,156.39 and is scheduled for completion by September 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of HUMIRA(CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. This firm fixed-price delivery order, valued at $1,132.95, represents a non-set-aside competitive award with an ultimate completion date of September 4, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,888.25 delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...